Demonstrating the psychometric properties of a problem‐related distress screener in a community sample of 319 cancer survivors
- 27 June 2012
- journal article
- research article
- Published by Wiley in Psycho-Oncology
- Vol. 22 (6) , 1249-1257
Abstract
Objective: The purpose was to test the psychometric properties of a 36‐item community‐based problem‐related distress screening tool, among 319 cancer survivors recruited across 14 affiliates of the Cancer Support Community.Methods: Internal reliability was estimated using Cronbach's alpha coefficient. Test–retest reliability was assessed using the intra‐class correlation coefficient (ICC). Concurrent validity was determined by correlations with the Functional Assessment of Cancer Therapy‐General Well‐Being Scale (FACT‐G), the Center for Epidemiologic Studies Depression Scale (CES‐D), and the Distress Thermometer (DT) and receiver operating characteristic (ROC) curve analysis using the CES‐D (≥16) and DT (≥4) as the criterion. Non‐parametric analysis of variance was used to establish discriminant validity.Results: The distress screener demonstrated high internal consistency (Cronbach's alpha = 0.91) and strong test–retest reliability (ICC ≥ 0.75). Summary scores of the distress screener correlated substantially with the FACT‐G (R2 = 0.58, p < 0.001), CES‐D (R2 = 0.48, p < 0.001), and DT (R2 = 0.35, p < 0.001) indicating strong concurrent validity and were able to discriminate groups of clinical relevance. ROC analyses showed a cutoff score of 8 for problem items rated ≥3 had optimal sensitivity and specificity relative to the CES‐D and DT.Conclusions: The distress screener shows strong psychometric properties and can be considered a valuable community‐based instrument to screen for psychological distress related to social, emotional, physical, and other patient‐related symptoms and problems. This study is the first to address the chasm between hospital and community‐based screening by validating a community‐based instrument and has begun to demonstrate the feasibility of screening in the community. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
Funding Information
- Genentech
- Eli Lilly and Company Foundation
- Pfizer
This publication has 30 references indexed in Scilit:
- The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinementPsycho-Oncology, 2011
- What do 1281 distress screeners tell us about cancer patients in a community cancer center?Psycho-Oncology, 2011
- Decrease in Depression Symptoms Is Associated With Longer Survival in Patients With Metastatic Breast Cancer: A Secondary AnalysisJournal of Clinical Oncology, 2011
- Comprehensive needs assessment tool in cancer (CNAT): the development and validationSupportive Care in Cancer, 2010
- The development and evaluation of a measure to assess cancer survivors' unmet supportive care needs: the CaSUN (Cancer Survivors' Unmet Needs measure)Psycho-Oncology, 2006
- Psychiatric morbidity and its recognition by doctors in patients with cancerBritish Journal of Cancer, 2001
- Development and validation of brief measures of positive and negative affect: The PANAS scales.Journal of Personality and Social Psychology, 1988
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- The CES-D ScaleApplied Psychological Measurement, 1977
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951